{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:42:43Z","timestamp":1770813763508,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00108-019-0590-y","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T13:02:53Z","timestamp":1552914173000},"page":"450-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Minimal-change-Glomerulonephritis und fokal-segmentale Glomerulosklerose","Minimal change disease and focal segmental glomerulosclerosis"],"prefix":"10.1007","volume":"60","author":[{"given":"J.","family":"M\u00fcller-Deile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/ijn.IJN_256_16","volume":"28","author":"K Ganesh","year":"2018","unstructured":"Ganesh K, Nair RR, Seethalekshmy NV et\u00a0al (2018) A study of clinical presentation and correlative Histopathological patterns in renal Parenchymal disease. Indian J Nephrol 28:28\u201334","journal-title":"Indian J Nephrol"},{"key":"590_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A et al (2007) Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2:445\u2013453","journal-title":"Clin J Am Soc Nephrol"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5414\/CNP63381","volume":"63","author":"M Almansori","year":"2005","unstructured":"Almansori M, Kovithavongs T, Qarni MU (2005) Cyclooxygenase-2 inhibitor-associated minimal-change disease. Clin Nephrol 63:381\u2013384","journal-title":"Clin Nephrol"},{"issue":"Suppl 6","key":"590_CR4","first-page":"52","volume":"18","author":"RJ Glassock","year":"2003","unstructured":"Glassock RJ (2003) Secondary minimal change disease. Nephrol Dial Transplant 18(Suppl 6):52\u201358","journal-title":"Nephrol Dial Transplant"},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0002-9343(86)90049-5","volume":"80","author":"DJ Dabbs","year":"1986","unstructured":"Dabbs DJ, Striker LM, Mignon F, Striker G (1986) Glomerular lesions in lymphomas and leukemias. Am J Med 80:63\u201370","journal-title":"Am J Med"},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","volume":"69","author":"V Audard","year":"2006","unstructured":"Audard V, Larousserie F, Grimbert P et\u00a0al (2006) Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: Report of 21 cases and review of the literature. Kidney Int 69:2251\u20132260","journal-title":"Kidney Int"},{"key":"590_CR7","first-page":"125","volume":"38","author":"Z Korzets","year":"1992","unstructured":"Korzets Z, Golan E, Manor Y et\u00a0al (1992) Spontaneously remitting minimal change nephropathy preceding a\u00a0relapse of Hodgkin\u2019s disease by 19\u00a0months. Clin Nephrol 38:125\u2013127","journal-title":"Clin Nephrol"},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000186877","volume":"61","author":"A Meyrier","year":"1992","unstructured":"Meyrier A, Delahousse M, Callard P, Rainfray M (1992) Minimal change nephrotic syndrome revealing solid tumors. Nephron 61:220\u2013223","journal-title":"Nephron"},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000013365","volume":"18","author":"T Auguet","year":"1998","unstructured":"Auguet T, Lorenzo A, Colomer E et\u00a0al (1998) Recovery of minimal change nephrotic syndrome and acute renal failure in a\u00a0patient with Renal cell carcinoma. Am J Nephrol 18:433\u2013435","journal-title":"Am J Nephrol"},{"issue":"5","key":"590_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P (2018) Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int 94(5):861\u2013869. https:\/\/doi.org\/10.1016\/j.kint.2018.04.024","journal-title":"Kidney Int"},{"key":"590_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cei.12675","volume":"183","author":"R Bertelli","year":"2016","unstructured":"Bertelli R, Bonanni A, Di Donato A et\u00a0al (2016) Regulatory T cells and minimal change nephropathy: In the midst of a\u00a0complex network. Clin Exp Immunol 183:166\u2013174","journal-title":"Clin Exp Immunol"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2249.2011.04441.x","volume":"166","author":"R Bertelli","year":"2011","unstructured":"Bertelli R, Bodria M, Nobile M et\u00a0al (2011) Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome. Clin Exp Immunol 166:55\u201363","journal-title":"Clin Exp Immunol"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"e30523","DOI":"10.1371\/journal.pone.0030523","volume":"7","author":"V Audard","year":"2012","unstructured":"Audard V, Pawlak A, Candelier M et al (2012) Upregulation of nuclear factor-related kappa B suggests a\u00a0disorder of transcriptional regulation in minimal change nephrotic syndrome. PLoS ONE 7:e30523","journal-title":"PLoS ONE"},{"key":"590_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI32022","volume":"117","author":"S Sever","year":"2007","unstructured":"Sever S, Altintas MM, Nankoe SR et\u00a0al (2007) Proteolytic processing of dynamin by cytoplasmic cathepsin L is a\u00a0mechanism for proteinuric kidney disease. J\u00a0Clin Invest 117:2095\u20132104","journal-title":"J Clin Invest"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C et al (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117\u2013122","journal-title":"Nat Med"},{"key":"590_CR16","doi-asserted-by":"publisher","first-page":"e0176198","DOI":"10.1371\/journal.pone.0176198","volume":"12","author":"G Cara-Fuentes","year":"2017","unstructured":"Cara-Fuentes G, Segarra A, Silva-Sanchez C et al (2017) Angiopoietin-like-4 and minimal change disease. PLoS ONE 12:e176198","journal-title":"PLoS ONE"},{"key":"590_CR17","first-page":"ra39","volume":"3","author":"SY Zhang","year":"2010","unstructured":"Zhang SY, Kamal M, Dahan K et al (2010) C\u2011Mip impairs Podocyte proximal signaling and induces heavy Proteinuria. Sci Signal 3:ra39","journal-title":"Sci Signal"},{"key":"590_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/70932","volume":"5","author":"H Dong","year":"1999","unstructured":"Dong H, Zhu G, Tamada K, Chen L (1999) B7-H1, a\u00a0third member of the B7 family, co-stimulates T\u2011cell proliferation and interleukin-10 secretion. Nat Med 5:1365\u20131369","journal-title":"Nat Med"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M et al (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J\u00a0Clin Invest 113:1390\u20131397","journal-title":"J Clin Invest"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.2007080836","volume":"20","author":"EH Garin","year":"2009","unstructured":"Garin EH, Diaz LN, Mu W et al (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J\u00a0Am Soc Nephrol 20:260\u2013266","journal-title":"J Am Soc Nephrol"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM et\u00a0al (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78:296\u2013302","journal-title":"Kidney Int"},{"key":"590_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1681\/ASN.2013050518","volume":"25","author":"P Fiorina","year":"2014","unstructured":"Fiorina P, Vergani A, Bassi R et al (2014) Role of podocyte B7-1 in diabetic nephropathy. J\u00a0Am Soc Nephrol 25:1415\u20131429","journal-title":"J Am Soc Nephrol"},{"key":"590_CR23","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A et al (2013) Abatacept in B7-1-positive proteinuric kidney disease. N\u00a0Engl J Med 369:2416\u20132423","journal-title":"N Engl J Med"},{"key":"590_CR24","doi-asserted-by":"publisher","first-page":"F335","DOI":"10.1152\/ajprenal.00510.2015","volume":"310","author":"R Novelli","year":"2016","unstructured":"Novelli R, Gagliardini E, Ruggiero B et al (2016) Any value of podocyte B7-1 as a\u00a0biomarker in human MCD and FSGS? Am J Physiol Renal Physiol 310:F335\u201341","journal-title":"Am J Physiol Renal Physiol"},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1681\/ASN.2015030266","volume":"27","author":"E Gagliardini","year":"2016","unstructured":"Gagliardini E, Novelli R, Corna D et al (2016) B7-1 is not induced in Podocytes of human and experimental diabetic Nephropathy. J\u00a0Am Soc Nephrol 27:999\u20131005","journal-title":"J Am Soc Nephrol"},{"key":"590_CR26","first-page":"1263","volume":"370","author":"N Alachkar","year":"2014","unstructured":"Alachkar N, Carter-Monroe N, Reiser J (2014) Abatacept in B7-1-positive proteinuric kidney disease. N\u00a0Engl J Med 370:1263\u20131264","journal-title":"N Engl J Med"},{"key":"590_CR27","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK et al (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J\u00a0Am Soc Nephrol 18:1476\u20131485","journal-title":"J Am Soc Nephrol"},{"key":"590_CR28","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/eji.1830250604","volume":"25","author":"H Kimata","year":"1995","unstructured":"Kimata H, Fujimoto M, Furusho K (1995) Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 25:1497\u20131501","journal-title":"Eur J Immunol"},{"key":"590_CR29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B et al (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse. J\u00a0Am Soc Nephrol 10:529\u2013537","journal-title":"J Am Soc Nephrol"},{"key":"590_CR30","doi-asserted-by":"publisher","first-page":"F26","DOI":"10.1152\/ajprenal.0102.2001","volume":"282","author":"JG Berg van den","year":"2002","unstructured":"van den Berg JG, Aten J, Annink C et al (2002) Interleukin-4 and -13 promote basolateral secretion of H(+) and cathepsin L by glomerular epithelial cells. Am J Physiol Renal Physiol 282:F26\u2013F33","journal-title":"Am J Physiol Renal Physiol"},{"key":"590_CR31","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","volume":"20","author":"WW Bakker","year":"2005","unstructured":"Bakker WW, van Dael CM, Pierik LJ et\u00a0al (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20:1410\u20131415","journal-title":"Pediatr Nephrol"},{"key":"590_CR32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0002-9343(81)90760-9","volume":"70","author":"BJ Carrie","year":"1981","unstructured":"Carrie BJ, Salyer WR, Myers BD (1981) Minimal change nephropathy: An electrochemical disorder of the glomerular membrane. Am J Med 70:262\u2013268","journal-title":"Am J Med"},{"key":"590_CR33","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1172\/JCI116831","volume":"92","author":"A Guasch","year":"1993","unstructured":"Guasch A, Deen WM, Myers BD (1993) Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J\u00a0Clin Invest 92:2274\u20132282","journal-title":"J Clin Invest"},{"key":"590_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1681\/ASN.2011090947","volume":"23","author":"B Weinhold","year":"2012","unstructured":"Weinhold B, Sellmeier M, Schaper W et\u00a0al (2012) Deficits in sialylation impair podocyte maturation. J\u00a0Am Soc Nephrol 23:1319\u20131328","journal-title":"J Am Soc Nephrol"},{"key":"590_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000183008","volume":"34","author":"M Oberholzer","year":"1983","unstructured":"Oberholzer M, Torhorst J, Perret E, Mihatsch MJ (1983) Minimum sample size of kidney biopsies for semiquantitative and quantitative evaluation. Nephron 34:192\u2013195","journal-title":"Nephron"},{"issue":"2","key":"590_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group","year":"2012","unstructured":"Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Internat Suppl 2(2):139\u2013274","journal-title":"Kidney Internat Suppl"},{"key":"590_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1445-5994.1983.tb04479.x","volume":"13","author":"CK Yeung","year":"1983","unstructured":"Yeung CK, Wong KL, Ng WL (1983) Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome. Aust N Z J Med 13:349\u2013351","journal-title":"Aust N Z J Med"},{"key":"590_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T et al (2002) Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 39:503\u2013512","journal-title":"Am J Kidney Dis"},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","volume":"18","author":"KC Tse","year":"2003","unstructured":"Tse KC, Lam MF, Yip PS et\u00a0al (2003) Idiopathic minimal change nephrotic syndrome in older adults: Steroid responsiveness and pattern of relapses. Nephrol Dial Transplant 18:1316\u20131320","journal-title":"Nephrol Dial Transplant"},{"key":"590_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","volume":"24","author":"J Hogan","year":"2013","unstructured":"Hogan J, Radhakrishnan J (2013) The treatment of minimal change disease in adults. J\u00a0Am Soc Nephrol 24:702\u2013711","journal-title":"J Am Soc Nephrol"},{"key":"590_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P et al (2014) Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J\u00a0Am Soc Nephrol 25:850\u2013863","journal-title":"J Am Soc Nephrol"},{"key":"590_CR42","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2215\/CJN.08500815","volume":"11","author":"P Ravani","year":"2016","unstructured":"Ravani P, Bonanni A, Rossi R et al (2016) Anti-CD20 antibodies for idiopathic Nephrotic syndrome in children. Clin J Am Soc Nephrol 11:710\u2013720","journal-title":"Clin J Am Soc Nephrol"},{"key":"590_CR43","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2014080799","volume":"26","author":"P Ravani","year":"2015","unstructured":"Ravani P, Rossi R, Bonanni A et al (2015) Rituximab in children with steroid-dependent Nephrotic syndrome: A Multicenter, open-label, Noninferiority, randomized controlled trial. J\u00a0Am Soc Nephrol 26:2259\u20132266","journal-title":"J Am Soc Nephrol"},{"key":"590_CR44","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ki.2013.211","volume":"84","author":"P Ravani","year":"2013","unstructured":"Ravani P, Ponticelli A, Siciliano C et al (2013) Rituximab is a\u00a0safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84:1025\u20131033","journal-title":"Kidney Int"},{"key":"590_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002231","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C et\u00a0al (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3(85). https:\/\/doi.org\/10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"key":"590_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.V7149","volume":"7","author":"G Fuiano","year":"1996","unstructured":"Fuiano G, Comi N, Magri P et\u00a0al (1996) Serial morphometric analysis of sclerotic lesions in primary \u201cfocal\u201d segmental glomerulosclerosis. J\u00a0Am Soc Nephrol 7:49\u201355","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"590_CR47","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1523-1755.2004.00833.x","volume":"66","author":"F Rivera","year":"2004","unstructured":"Rivera F, Lopez-Gomez JM, Perez-Garcia R, Spanish Registry of Glomerulonephritis (2004) Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66(3):898\u2013904. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00833.x","journal-title":"Kidney Int"},{"issue":"6","key":"590_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","volume":"23","author":"SM Korbet","year":"1994","unstructured":"Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23(6):773\u2013783","journal-title":"Am J Kidney Dis"},{"key":"590_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3295618","author":"M Rudnicki","year":"2016","unstructured":"Rudnicki M (2016) FSGS recurrence in adults after renal transplantation. Biomed Res Int. https:\/\/doi.org\/10.1155\/2016\/3295618","journal-title":"Biomed Res Int"},{"issue":"6","key":"590_CR50","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1046\/j.1523-1755.2000.00434.x","volume":"58","author":"L Berre Le","year":"2000","unstructured":"Le Berre L, Godfrin Y, Lafond-Puyet L, Perretto S, Le Carrer D, Bouhours JF et al (2000) Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria. Kidney Int 58(6):2502\u20132511","journal-title":"Kidney Int"},{"issue":"5","key":"590_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1056\/NEJM200102013440517","volume":"344","author":"MJ Kemper","year":"2001","unstructured":"Kemper MJ, Wolf G, Muller-Wiefel DE (2001) Transmission of glomerular permeability factor from a\u00a0mother to her child. N\u00a0Engl J Med 344(5):386\u2013387","journal-title":"N Engl J Med"},{"issue":"8","key":"590_CR52","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J et\u00a0al (2011) Circulating urokinase receptor as a\u00a0cause of focal segmental glomerulosclerosis. Nat Med 17(8):952\u2013960","journal-title":"Nat Med"},{"issue":"11","key":"590_CR53","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: When and how? Nephrol Dial Transplant 31(11):1802\u20131813","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"590_CR54","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1172\/JCI45693","volume":"121","author":"SF Heeringa","year":"2011","unstructured":"Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z et\u00a0al (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J\u00a0Clin Invest 121(5):2013\u20132024","journal-title":"J Clin Invest"},{"issue":"6","key":"590_CR55","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00467-013-2482-z","volume":"29","author":"F Ozaltin","year":"2014","unstructured":"Ozaltin F (2014) Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies. Pediatr Nephrol 29(6):961\u2013969","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"590_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D\u2019Agati","year":"2004","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: A\u00a0working proposal. Am J Kidney Dis 43(2):368\u2013382","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"590_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/jca.21538","volume":"32","author":"H Schenk","year":"2017","unstructured":"Schenk H, Muller-Deile J, Schmitt R, Brasen JH, Haller H, Schiffer M (2017) Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb. J\u00a0Clin Apher 32(6):444\u2013452","journal-title":"J Clin Apher"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0590-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:30:54Z","timestamp":1694709054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0590-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0590-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"18 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0M\u00fcller-Deile, H.\u00a0Schenk und M.\u00a0Schiffer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}